Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone
NCT00917241
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
218
Enrollment
OTHER
Sponsor class
Conditions
Graves' Disease
Interventions
DRUG:
MMI combined with IID
DRUG:
MMI
Sponsor
Xiao-Ming Mao